NewsRx Logo Login/Signup
Home Newsletters Products Library About Us Contact -- Search NewsRx

NewsRx | Free Trials
Advertisement
VerticalNews | Global Warming
NewsRx | Free Newsletters
 
----------
------------
NewsRx on Facebook
-----
NewsRx Passes
Press Release Submissions
PR Login
-----
2008 Award Logo
Best e-Business Site, 2009
Best e-Business Site, 2008
Best e-Business Site, 2007
Best e-Business Site, 2006
Best Healthcare Content, 2005
Best Overall Internet Site, 2005
Best Interactive Site, 2005
-----
Google 2009 PageRank: #2 Among Top Health News and Media Publications
Google 2009 PageRank: #2 Among Top Science Publications in Biology/Physiology
Google 2009 PageRank: #2 Among Top News and Media for the Business of Pharmaceuticals
Amazon's Alexa 2009 PageRank: #2 News and Media Site for the Pharmaceutical Industry
NewsRx also is available at LexisNexis, Gale, ProQuest, Factiva, Dialog, Thomson Reuters, NewsEdge, and Dow Jones.

This website is certified by Health On the Net Foundation. Click to verify. This site complies with the HONcode standard for trustworthy health information:
verify here.

Security by Verisign

Dacryocystitis


Return to Library

Free Dacryocystitis Articles


Researchers' work from Raigmore Hospital focuses on dacryocystorhinostomy



2009 MAY 12 - (NewsRx.com) -- In this recent article published in the journal Rhinology, scientists in Scotland conducted a study "To measure the effect of Endonasal DCR on the health status of patients, using a validated outcomes measure, the Glasgow Benefit Inventory. Postal questionnaire with telephone follow up of patients undergoing Endonasal DCR in two institutions in Scotland."

"The same surgical technique is used in both centres. Patients were identified from prospectively collected data on consecutive patients undergoing this procedure. All adult patients, a minimum of twelve months post-intervention, were included. Ninety two of 123 patients (75%) completed the questionnaire, the mean age was 59 years and the sex ratio m:f was 1:1.8. The mean overall GBI for this intervention was + 32.7 (95% confidence intervals 27.8-37.6). The patients were grouped according to the indication for intervention: Obstruction of Iacrimal system GBI + 32.7 (26.3-37.1), mucoecele + 40.1 (28.7-51.4), dacryocystitis + 19.4 (10.0-28.9). The GBI provides a measure of the effect of an ORL intervention on the health of a patient. Endonasal DCR scores highly when compared with a number of other rhinological procedures including rhinoplasty (GBI + 20), endoscopic sinus surgery (GBI + 23), and septal surgery (mean ranges from + 6 to + 24)," wrote P.M. Spielmann and colleagues, Raigmore Hospital.

The researchers concluded: "Endonasal DCR is a successful intervention with demonstrable health benefits to the patient."

Spielmann and colleagues published their study in Rhinology (The impact of endonasal dacryocystorhinostomy (DCR), on patient health status as assessed by the Glasgow benefit inventory. Rhinology, 2009;47(1):48-50).

Additional information can be obtained by contacting P.M. Spielmann, Raigmore Hospital, Dept. of Otorhinolaryngology, Old Perth Rd., Inverness IV2 34J, Scotland.

The publisher of the journal Rhinology can be contacted at: International Rhinologic Society, University Medical Center Utrecht, RM G05 127, Dept. Otorhinol, Heidelberglaan 100, 3584 Cx Utrecht, Netherlands.

Keywords: Scotland, Dacryocystorhinostomy, Rhinology, Surgery, Raigmore Hospital.

This article was prepared by Life Science Weekly editors from staff and other reports. Copyright 2009, Life Science Weekly via NewsRx.com.

NewsRx NewsRx NewsRx
-----------------------
PR Login